Günter Weiss

1.6k total citations
15 papers, 1.2k citations indexed

About

Günter Weiss is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Günter Weiss has authored 15 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Günter Weiss's work include Epigenetics and DNA Methylation (7 papers), Cancer Genomics and Diagnostics (6 papers) and Colorectal Cancer Screening and Detection (4 papers). Günter Weiss is often cited by papers focused on Epigenetics and DNA Methylation (7 papers), Cancer Genomics and Diagnostics (6 papers) and Colorectal Cancer Screening and Detection (4 papers). Günter Weiss collaborates with scholars based in Germany, United States and United Kingdom. Günter Weiss's co-authors include Reimo Tetzner, Catherine Lofton–Day, Thomas König, Nicholas T. Potter, Jürgen Distler, Theo deVos, Thomas Koenig, Matthias Schuster, Anne Schlegel and Denise Kottwitz and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Urology.

In The Last Decade

Günter Weiss

15 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Günter Weiss Germany 11 712 548 464 370 350 15 1.2k
Andrew Sledziewski Germany 6 800 1.1× 592 1.1× 576 1.2× 241 0.7× 506 1.4× 7 1.3k
Jerry Haney United States 7 846 1.2× 362 0.7× 482 1.0× 296 0.8× 160 0.5× 12 1.2k
Mireille H.J. Snel Netherlands 13 348 0.5× 383 0.7× 545 1.2× 157 0.4× 307 0.9× 18 994
Yuchen Bai United States 14 693 1.0× 226 0.4× 452 1.0× 218 0.6× 186 0.5× 21 1.0k
Atocha Romero Spain 20 612 0.9× 767 1.4× 567 1.2× 453 1.2× 240 0.7× 66 1.4k
Hui-Zhong Zhang China 15 599 0.8× 317 0.6× 326 0.7× 118 0.3× 233 0.7× 18 893
Carmen Say United States 4 471 0.7× 734 1.3× 372 0.8× 406 1.1× 201 0.6× 9 1.0k
Brooke E. Sylvester United States 8 337 0.5× 329 0.6× 441 1.0× 179 0.5× 292 0.8× 9 824
Joel Greenbowe United States 13 338 0.5× 529 1.0× 780 1.7× 531 1.4× 258 0.7× 20 1.1k
David Cordero Spain 14 392 0.6× 232 0.4× 242 0.5× 223 0.6× 197 0.6× 23 728

Countries citing papers authored by Günter Weiss

Since Specialization
Citations

This map shows the geographic impact of Günter Weiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Günter Weiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Günter Weiss more than expected).

Fields of papers citing papers by Günter Weiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Günter Weiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Günter Weiss. The network helps show where Günter Weiss may publish in the future.

Co-authorship network of co-authors of Günter Weiss

This figure shows the co-authorship network connecting the top 25 collaborators of Günter Weiss. A scholar is included among the top collaborators of Günter Weiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Günter Weiss. Günter Weiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Lewin, Jörn, Denise Kottwitz, Theo deVos, et al.. (2021). Plasma cell free DNA methylation markers for hepatocellular carcinoma surveillance in patients with cirrhosis: a case control study. BMC Gastroenterology. 21(1). 136–136. 31 indexed citations
3.
Weiss, Günter, Anne Schlegel, Denise Kottwitz, Thomas König, & Reimo Tetzner. (2016). Validation of the SHOX2 / PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease. Journal of Thoracic Oncology. 12(1). 77–84. 128 indexed citations
5.
Weiss, Günter, et al.. (2016). 31PD DNA methylation of SHOX2 and PTGER4 as a plasma-based tool to differentiate between patients with malignant and benign lung disease. Journal of Thoracic Oncology. 11(4). S68–S68. 1 indexed citations
6.
Liles, Elizabeth, Gloria D. Coronado, Nancy Perrin, et al.. (2016). Uptake of a colorectal cancer screening blood test is higher than of a fecal test offered in clinic: A randomized trial. Cancer Treatment and Research Communications. 10. 27–31. 36 indexed citations
7.
Johnson, David A., Robert L. Barclay, Klaus Mergener, et al.. (2014). Plasma Septin9 versus Fecal Immunochemical Testing for Colorectal Cancer Screening: A Prospective Multicenter Study. PLoS ONE. 9(6). e98238–e98238. 131 indexed citations
8.
Potter, Nicholas T., Patrick Hurban, Catherine Lofton–Day, et al.. (2014). Validation of a Real-Time PCR–Based Qualitative Assay for the Detection of Methylated SEPT9 DNA in Human Plasma. Clinical Chemistry. 60(9). 1183–1191. 215 indexed citations
9.
Weiss, Günter, et al.. (2012). Sensitivity of second-generation blood-based methylated Septin9 assay for early-stage colorectal cancer.. Journal of Clinical Oncology. 30(4_suppl). 419–419. 1 indexed citations
10.
Schatz, Philipp, Dimo Dietrich, Thomas Koenig, et al.. (2010). Development of a Diagnostic Microarray Assay to Assess the Risk of Recurrence of Prostate Cancer Based on PITX2 DNA Methylation. Journal of Molecular Diagnostics. 12(3). 345–353. 27 indexed citations
11.
Bañez, Lionel L., Leon Sun, Geert J. van Leenders, et al.. (2010). Multicenter Clinical Validation of PITX2 Methylation as a Prostate Specific Antigen Recurrence Predictor in Patients With Post-Radical Prostatectomy Prostate Cancer. The Journal of Urology. 184(1). 149–156. 67 indexed citations
12.
deVos, Theo, Reimo Tetzner, Fabian Model, et al.. (2009). Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer. Clinical Chemistry. 55(7). 1337–1346. 406 indexed citations
13.
Weiss, Günter, Susan Cottrell, Jürgen Distler, et al.. (2009). DNA Methylation of the PITX2 Gene Promoter Region is a Strong Independent Prognostic Marker of Biochemical Recurrence in Patients With Prostate Cancer After Radical Prostatectomy. The Journal of Urology. 181(4). 1678–1685. 83 indexed citations
14.
Cortese, Rene, Manuel Krispin, Günter Weiss, Kurt Berlin, & Florian Eckhardt. (2008). DNA methylation profiling of pseudogene–parental gene pairs and two gene families. Genomics. 91(6). 492–502. 9 indexed citations
15.
Cottrell, Susan, Klaus Jung, Glen Kristiansen, et al.. (2007). Discovery and Validation of 3 Novel DNA Methylation Markers of Prostate Cancer Prognosis. The Journal of Urology. 177(5). 1753–1758. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026